Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.53
0.01 (0.12%)
At close: Aug 18, 2025, 3:59 PM
8.54
0.12%
Pre-market: Aug 19, 2025, 07:15 AM EDT
Y-mAbs Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 85.39M | 88.66M | 87.69M | 84.55M | 86.55M | 84.5M | 84.82M | 92.9M | 84.99M | 75.03M | 65.27M | 43.42M | 39.85M | 40M | 34.9M | 46.05M | 37.08M | 26.13M |
Cost of Revenue | 15.75M | 16.11M | 15.25M | 9.45M | 9.85M | 11.48M | 11.42M | 11.4M | 11.23M | 7.82M | 7.57M | 7.01M | 5.08M | 4.25M | 2.51M | 3.26M | 2.71M | 2.3M |
Gross Profit | 69.63M | 72.55M | 72.43M | 75.11M | 76.7M | 73.02M | 73.4M | 81.51M | 73.76M | 67.21M | 57.7M | 36.41M | 34.76M | 35.75M | 32.38M | 42.79M | 34.38M | 23.84M |
Operating Income | -26.65M | -30.84M | -31.2M | -28.46M | -27.64M | -25.08M | -25.67M | -23.63M | -41.89M | -74.62M | -94.81M | -129.41M | -132.1M | -114.87M | -115.43M | -99.77M | -103.71M | -121.45M |
Interest Income | 1.66M | 2.3M | 1.39M | 5.4M | 3.67M | 4.13M | 4.81M | 2.4M | 2.21M | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59K |
Pretax Income | -22.62M | -28.53M | -29.81M | -23.06M | -23.97M | -20.95M | -20.87M | -18.92M | -38.88M | -73.89M | -95.57M | -133.62M | -134.95M | -116.76M | -55.27M | -38.31M | -42.29M | -59.74M |
Net Income | -22.22M | -28.23M | -29.67M | -23.86M | -24.61M | -21.67M | -20.13M | -17.99M | -39.28M | -75.29M | -98.64M | -136.69M | -136.51M | -117.13M | -55.27M | -38.31M | -42.29M | -59.74M |
Selling & General & Admin | 50.39M | 56.31M | 54.65M | 53.41M | 49.99M | 44.03M | 44.86M | 44.51M | 47.94M | 59.75M | 60.94M | 65.28M | 65.65M | 56.04M | 54.57M | 54.06M | 51.71M | 48.63M |
Research & Development | 45.84M | 47.08M | 48.99M | 50.16M | 54.35M | 54.07M | 54.22M | 60.62M | 67.71M | 82.08M | 91.57M | 100.54M | 101.22M | 94.58M | 93.25M | 88.5M | 86.37M | 96.65M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210K | 210K | 210K | 210K | 2.2M | 2.2M | 2.2M |
Operating Expenses | 96.23M | 103.39M | 103.64M | 103.57M | 104.35M | 98.1M | 99.08M | 105.13M | 115.65M | 141.83M | 152.51M | 165.83M | 166.87M | 150.62M | 147.82M | 142.56M | 138.08M | 145.28M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.51M | 2.69M | 3.07M | 4.2M | 2.85M | 1.89M | 1.85M | 1.31M | 1.35M | 1.13M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 111.99M | 119.49M | 118.89M | 113.02M | 114.19M | 109.58M | 110.49M | 116.53M | 126.88M | 149.65M | 160.08M | 172.83M | 171.95M | 154.87M | 150.33M | 143.62M | 138.59M | 145.38M |
Income Tax Expense | -394K | -301K | -146K | 801K | 642K | 721K | -732K | -927K | 395K | 1.4M | 3.07M | 3.07M | 1.56M | 157K | -216K | -216K | -216K | n/a |
Shares Outstanding (Basic) | 45.32M | 45.1M | 44.88M | 44.63M | 44.02M | 43.78M | 43.63M | 43.62M | 43.66M | 43.67M | 43.67M | 43.69M | 43.72M | 43.71M | 43.6M | 43.6M | 43.28M | 41.87M |
Shares Outstanding (Diluted) | 45.32M | 45.1M | 44.88M | 44.63M | 44.02M | 43.78M | 43.63M | 43.62M | 43.66M | 43.67M | 44.69M | 43.72M | 43.72M | 43.71M | 43.6M | 43.6M | 43.57M | 44.38M |
EPS (Basic) | -0.5 | -0.64 | -0.67 | -0.54 | -0.56 | -0.49 | -0.46 | -0.41 | -0.89 | -1.72 | -2.25 | -3.13 | -3.13 | -2.69 | -1.24 | -0.87 | -1.03 | -1.51 |
EPS (Diluted) | -0.5 | -0.64 | -0.67 | -0.54 | -0.56 | -0.49 | -0.46 | -0.41 | -0.89 | -1.72 | -2.25 | -3.13 | -3.13 | -2.69 | -1.29 | -0.89 | -1.05 | -1.53 |
EBITDA | -26.43M | -30.46M | -30.67M | -27.87M | -27M | -24.37M | -25.12M | -23M | -41.21M | -74.16M | -94.16M | -128.7M | -131.47M | -114.02M | -114.65M | -99.16M | -103.15M | -121.01M |
EBIT | -22.93M | -29.48M | -31.2M | -28.46M | -27.64M | -25.08M | -25.67M | -23.63M | -41.89M | -75.8M | -96M | -130.6M | -133.29M | -114.87M | -53.42M | -37.76M | -41.7M | -59.44M |
Depreciation & Amortization | 294K | 447K | 535K | 594K | 641K | 712K | 735K | 804K | 862K | 826K | 839K | 900K | 819K | 847K | 782K | 608K | 556K | 440K |